✦ LIBER ✦

Assessment of the Key Drivers of Cost-Effectiveness in the Economic Modelling of Canagliflozin (CANA) Versus Glimepiride (GLIM) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK Setting

✍ Scribed by Thompson, G.; Willis, M.; Johansen, P.; Neslusan, C.; Schroeder, M.; Girod, I.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sources of Long-Term Quality Adjusted Li

✍ Girod, I.; Willis, M.; Johansen, P.; Schroeder, M.; Thompson, G.; Neslusan, C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Sources of Long-Term Quality Adjusted Li

✍ Willis, M.; Johansen, P.; Schroeder, M.; Thompson, G.; Girod, I.; Neslusan, C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PDB37 THE COST-EFFECTIVENESS OF SAXAGLIP

✍ K Kolasa; M Niewada; J Puelles Fernandez de Troconiz; R Townsend; P McEwan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PDB44 THE COST-EFFECTIVENESS OF SAXAGLIP

✍ W Erhardt; K Bergenheim; R Townsend; J Puelles Fernandez de Troconiz; P McEwan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

The Cost-Effectiveness of Dapagliflozin

✍ Charokopou, M.; McEwan, P.; Lister, S.; Callan, L.; Bergenheim, K.; Tolley, K.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

The Cost-Effectiveness of Dapagliflozin

✍ Charokopou, M.; McEwan, P.; Lister, S.; Callan, L.; Bergenheim, K.; Tolley, K.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB